Zoe Arvanitakis to Cognitive Dysfunction
This is a "connection" page, showing publications Zoe Arvanitakis has written about Cognitive Dysfunction.
Connection Strength
2.097
-
Metformin, age-related cognitive decline, and brain pathology. Neurobiol Aging. 2024 Jan; 133:99-106.
Score: 0.551
-
Insulin resistance, cognition, and Alzheimer disease. Obesity (Silver Spring). 2023 06; 31(6):1486-1498.
Score: 0.537
-
Antiphospholipid Antibodies: Cognitive and Motor Decline, Neuroimaging and Neuropathology. Neuroepidemiology. 2019; 53(1-2):100-107.
Score: 0.405
-
A multidomain trial for cognition in women with cardiovascular disease. Alzheimers Dement. 2025 06; 21(6):e70285.
Score: 0.154
-
The MindMoves Trial: Cross-Sectional Analyses of Baseline Vascular Risk and Cognition in Older Women with Cardiovascular Disease. J Alzheimers Dis. 2024; 100(4):1407-1416.
Score: 0.140
-
A study protocol for MindMoves: A lifestyle physical activity and cognitive training intervention to prevent cognitive impairment in older women with cardiovascular disease. Contemp Clin Trials. 2021 02; 101:106254.
Score: 0.114
-
Changes in Body Mass Index Are Related to Faster Cognitive Decline Among African American Older Adults. J Am Geriatr Soc. 2020 11; 68(11):2662-2667.
Score: 0.112
-
Cognitive decline following incident and preexisting diabetes mellitus in a population sample. Neurology. 2016 Oct 18; 87(16):1681-1687.
Score: 0.084